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Tlssue-specffic modulation of Na, K-ATPase a-subunit gene expression
in uremic rats. Chronic renal failure in the rat is associated with an
impaired extrarenal potassium handling, whereas a renal adaptive
mechanism of the remaining nephrons has been described. To under-
stand the molecular basis of potassium homeostasis during renal failure
we investigated the in vitro pump activity and the catalytic mRNA
transcription in three different tissues: skeletal muscle, isolated adipo-
cytes and kidney. The activity of the sodium pump, as measured by
ouabain-sensitive 86Rb/K uptake in isolated adipocytes and skeletal
muscle fibers, revealed a significant reduction of the pump activity in
uremic rats. The reduction of the Na, K-ATPase activity in adipose
tissue was associated with a similar decrement of both catalytic
subunits (al and a2), whereas in the skeletal muscle tissue was only
related to a decrease in the activity of the a! isoform. The expression of
rat Na, K-ATPase catalytic isoforms mRNAs in kidney, muscle and
adipose tissue from control and chronic renal failure rats was investi-
gated at the molecular level with cDNA probes specific for the catalytic
isoforms (al and a2). Northern blot analysis revealed that the respec-
tive catalytic mRNAs of uremic rats are regulated in a tissue-specific
manner that are in agreement with the sodium-potassium pump activity.
Muscle and adipose tissue showed a decrement in the levels of
expression for the al isoform mRNA. In contrast to these tissues, an
increment in al mRNA expression was observed in the kidney of rats
with chronic renal failure. The a2 mRNA was expressed primarily in
muscle and adipose tissue, but only in this last tissue was a decrement
in the expression observed. Then, each tissue examined exhibits a
distinct pattern of expression for the Na, K-ATPase catalytic a iso-
forms during chronic renal failure.
The sodium-potassium pump is an integral membrane protein
consisting of a and /3 subunits. It plays an essential role in
maintaining transmembrane gradients of sodium and potassium
ions in animal cells. The a-subunit is considered the catalytic
subunit, while the role of the /3 subunit has not yet been clearly
established [1, 2]. Three distinct forms of the catalytic subunit
are known. These three known isoforms of the a subunit (at, a2
and a3) are encoded by separate genes [3] and exhibit differ-
ences in tissue specificity, hormonal regulation, sodium sensi-
tivity and cardiac glycoside affinity [4—8]. In the rat, the al
isoform is expressed ubiquitously, whereas a2 is expressed
predominantly in skeletal muscle, adipocytes, brain and adult
heart, and a3 is expressed primarily in brain and fetal heart [5,
7, 8].
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The functioning of the Na, K-ATPase is essential for a variety
cell homeostatic processes including osmotic balance, cell
volume regulation and maintenance of the resting membrane
potential. In addition, certain specialized functions including
electrical excitability of nerve and muscle, and fluid movement
across kidney and intestinal transport epithelia require the
activity of the sodium pump.
Na-K pump activity in chronic renal failure has been studied
by several investigators. The remarkable adaptive increase in
potassium excretion by the remaining functioning nephrons has
being explained by the increment in the number of Na, K-
ATPase of the secretory epithelia [9—111. These results are of
particular interest because it is known that at isoform is
expressed in kidney epithelia tissue, and we have recently
showed a decrement in the expression and activity of al subunit
in muscle tissue of chronic renal failure rats [12]. The isozyme
specificity of renal adaptation is not known. The question of
interest here is whether the kidney of uremic rats could increase
the amount of mRNA for this isozyme. We studied the mRNAs
and pump activity of the a! and a2 isoforms of the Na,
K-ATPase in three different tissues: kidney, muscle and adipo-
cytes.
The results indicate that while chronic renal failure does lead
to an increment in the amount of mRNA for al isoform of the
Na-K pump in the kidney, the amounts of mRNAs for this
isozyme are diminished in adipose and muscle tissue. It was
found that in uremic animals a2 mRNA also decreased in
adipocytes, whereas the amount of the mRNA for a2 isoform
increased in uremic muscle fibers compared to normal rats.
Methods
Animals
Male Sprague-Dawley rats (—250 g) fed a standard rat chow
diet were used. Chronic renal failure was induced by ligating
branches of the artery to infarct about 3/4 of the kidney; a right
nephrectomy was performed after four days. The experiments
were done three to four weeks after surgery. Plasma creatinine
and blood urea nitrogen were controlled at the beginning of
each study.
RNA isolation and Northern blot analysis
After the rats were killed, soleus muscles and saline perfused
kidney were removed and immediately processed. Adipocytes
(from 3 to 5 rats) were prepared according to Resh, Nemenoff
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and Guidotti [13] as modified by McGill and Guidotti [14].
Briefly, epididymal fat pads were removed from 200 to 250 g
male rats immediately following decapitation. Digestion was
carried out in Krebs-Ringer phosphate buffer, containing 4%
(wtlvol) bovine serum albumin and 1 mg/mi of collagenase (type
1). The buffer contained 140 mM NaCI, 5 mrt KCI, 1.4 mM
CaCI2, 1 mM MgSO4, 10 m Na2HPO4 and was adjusted to pH
7.4 with Tris base after addition of albumin, followed by one
hour digestion at 37°C.
Total cellular RNA was extracted from —250 mg of tissue or
5 to 8 x 106 adipocytes using the guanidinium thyocianate.
RNA (25 g) was electrophoresed on 2.2 M formaldehyde-
agarose gels [15], blotted, washed with 50 mi NaOH and fixed
onto nylon membranes, and then hybridized to cDNA probes.
The a! and a2 cDNA was provided to us by Nelson Ruiz-
Opazo, Boston University [161.
Isoform-specific restriction endonuclease Barn HI fragments
were prepared from these probes [16]. The al and a2 cDNA
probes were labeled with digoxigenin-d UTP, using the non-
radioactive DNA labeling and detection kit from Boehringer
Mannheim Corp. (Indianapolis, Indiana, USA).
Membranes were hybridized to the corresponding probes for
five to six hours at 42°C in 50% formamide in 5x SSC (0.3 M
NaC1, 0.03 M sodium citrate) pH 7.0 with 5% of blocking
reagent, according to instruction recommended by the kit. Then
the membranes were washed at high stringency twice in 2 X
SSC with 0.1% SDS for one or two minutes each at room
temperature, then twice for 15 minutes each in 0.1 x SSC with
0.1% SDS at 68°C to assure the specificity of the Northern blot.
The hybridized membranes were detected immediately by the
enzyme-linked immunoassay system. The amount of mRNA
present in each sample was quantified by computer scanning
densitometry analysis, comparing the intensity of the experi-
mental sample to control rat mRNA samples or to the internal
standard GAPDH mRNA (glyceraldehyde-3-phosphate dehy-
drogenase) for each processed tissue. The specific cDNA probe
(p GAPDH-13) was provided by P. Carvallo, NIH.
Total cellular RNA was determined by spectrophotometer
[171 and protein content by the Hartree method [18].
Quantification dots on Northern blots. Color dots were
quantified with a scanning densitometer (Geniscan, Fremont,
California, USA) interfaced to an IBM PC 386 computer with a
GS-4500 scanner and specially written C program.
Sodium pump activity
The Na, K-ATPase activity was measured by ouabain-sensi-
tive 86Rb/K uptake or by the measurement of Pi released from
ATP. Total pump activity was calculated by the difference
between zero and 102 M ouabain; a2 activity was measured at
5 x 10—6 M or iO M ouabain.
86Rb transport in skeletal muscle
The muscle was removed from control and uremic animals
and then groups of fibers weighing 8 to 15 mg were incubated in
separate vials, as described by Goecke et al [12]. Briefly the
muscular fibers were washed for 15 minutes in 2 ml of KRB
containing (mM) 4.2 KCI; 1.19 KH2PO4; 120 NaCI; 25 NaHCO3;
1.2 MgSO4; 1.3 CaC12; 5-D-glucose (pH = 7.4). The buffer was
gassed with 95% 02 and 5% CO2. Thereafter, the muscles were
preincubated for 30 minutes in KRBG in the presence or
Table 1. Characteristics of control and uremic rats
ControlN= 80 CRFN= 80
Body weightg 255 4 255 5
Plasma creatinine mg/dl 0.44 0.01 1.59 0.07a
Blood urea nitrogen mg/dl 17.2 0.5 65.2 2.6a
Values of control and nephrectomized (CRF) rats are given as mean
SE.
a p < 0.001
absence of 10_2 M or i0-' M ouabain. Finally, the muscles were
incubated for 20 minutes in KRB containing 86Rb (0.1 jsCilml) in
the presence or absence of 10—2 M or lO M ouabain. The
reaction was stopped by transferring the muscle into iced
KRBG; the muscles were washed in cold buffer and blotted.
Radioactivity of the samples was determined by the Cerenkov
radiation in a liquid scintillation counter.
86Rb uptake in adipocytes
Uptake was measured essentially as described above for
muscle tissue and according to Lytton [6], and McGill and
Guidotti [14] when "max was measured. Briefly, isolated adipo-
cytes were incubated in the appropriate buffers at 20 to 30% cell
density in total volumes ranging from 0.3 to 1 ml for 15 to 30
minutes at 37°C with the indicated ouabain concentrations.
Uptake was initiated either by the addition of 86RbCl (2 to 5
CiJml) alone or by the addition of 86Rb and KCI (to a final
concentration of 5 mM). Uptake was terminated after the
indicated time by spinning 100 to 200 j.d aliquots through
dinonyl phthalate as described by Resh et al [13]. Cell cakes
were cut from tubes solubilized in 1% Triton, and counted by
Cerenkov method.
For experiments in which KC1 was omitted, cells were
washed an additional two to three times in the desired buffer.
86Rb uptake in kidney slices
The left kidney was removed decapsulated and sliced into
thin transversal sections. The slices were then thoroughly
rinsed in ice-cold KRBG. 86Rb uptake was measured, as
indicated above for muscular tissue. No attempts were made for
morphological identification of the tissue but transversal sec-
tions of control or uremic rats yield the best replicative results.
Na, K-ATPase hydrolytic activity
Na-pump activity was also determined by a colorimetric
assay based on the measurement of P1 released from ATP by the
ATPase of whole kidney or muscular homogenates, as de-
scribed by Lo et at [19]. Briefly, whole left kidney or soleus
muscle from control and uremic rats were homogenized in
sucrose, histidine, EDTA, pH 7.4. The crude homogenate was
centrifuged at 0 to 4°C. The 1,000 x g pellet was discarded. The
supernatants were stored overnigh at —20° and then analyzed
for enzyme activity. Aliquots of this crude homogenate were
taken for ATPase activity. After addition of ATPase assay
solution (see composition below), samples were incubated for
15 minutes at 37°C. Incubation was stopped by cooling and by
addition of 5% (wt/vol) cold trichloracetic acid. After centrifu-
gation, the Pi formed from ATP was measured colorimetrically
[19]. ATPase assay solution contained (mM): 50 NaC1, 5 KCI, 10
MgC12, 1 EDTA, 100 Tris HC1, 10 Na2 ATP for total ATPase
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Table 2. Na,K-ATPase activity in adipocytes and skeletal muscle of control and uremic rats
Tissue Conditions
Total pump
activity
al Isoform a2 Isoform
Activity % Of total Activity % Of total
Adipocytes Control 22.28 2.53 8.35 1.02 38.0 4.2 13.92 2.0 62.0 4.2
nmol/1 x 106 cells/mm CRF 14.25 1.638 5.57 0.968 38.2 4.2 8.69 0.988 61.8 4.2
Muscle Control 17.89 0.76 10.16 0.59 56.5 1.5 7.73 0.33 43.5 1.5
nmol/100 mg wet wt/min CRF 9.92 0.568 2.19 0.318 21.8 2.48 7.74 0.39 78.2 2.4a
Na-K pump activity was expressed as nmol of Rb uptake per nmol/l x 106 cells/mm in the case of adipocytes and nmol/100 mg wet wt/min
in skeletal muscle. Total pump activity was measured as the difference of total Rb uptake minus uptake with 10-2 M ouabain. The difference in
activity in the absence and presence of 10 M ouabain is taken as a2-activity, and that in the presence of 10 M and 1 mouabain is taken as
al-activity. Rb uptake was measured in triplicates samples; N =6 for adipocytes and N = 5 for skeletal muscle.
8 0.01 vs. controls
activity, For basal Mg-ATPase activity, NaCl and KC1 were
omitted, Tris HC1 was 150 m, and 1 mrt ouabain was added.
The pH of both solutions was adjusted to 7.4. In each experi-
ment, total and Mg-ATPase activities were each determined on
duplicates either for uremic or control rats. Na, K-ATPase
activity was taken as the difference between the mean total
ATPase and the mean Mg-ATPase activity. Na, K-ATPase
activity was expressed as pmol Pi/mg protein/hr and the data
are means SE from different animals.
Statistical analyses
Nonlinear least squares analysis was performed on a 386 IBM
Computer using the N fit 1.0 package of the University of
Texas, Medical Branch at Galveston, Texas. Significance was
determined with Student's t-test (paired). For densitometry
data, the results were evaluated as a percent of control blot
(GADPH) due to the arbitrary nature of OD units, as indicated
previously [15]. Differences were accepted as significant at the
P 0.05 level.
Results
The principal characteristics of experimental rats, three to
four weeks after partial nephrectomy, compared to control
animals are included in Table 1. The nephrectomized rats had
established renal insufficiency, as shown by plasma creatinine
and blood urea nitrogen, whereas both groups have similar
weights due to paired feeding of the rats. Previous studies by us
[121 have indicated that there are no alterations in acid-base
state with this degree of renal insufficiency.
The amount of the a isoforms of the Na, K-ATPase in the
kidney and in two extrarenal tissues (skeletal muscle and
adipose tissue) of normal and uremic rats were quantitated by
determination of the ouabain-inhibitable uptake of 86Rb and by
Northern analysis of the mRNAs.
Characterization of the isoforms of the Na, K-ATPase
In previous studies using the uremic rat model, we found a
decrement in Na, K-pump activity in skeletal muscle tissue
[15]. To establish a common reference base for comparisons of
Na, K-ATPase activity, in extrarenal tissue, we have measured
simultaneously the pump activity in isolated adipocytes and
muscle fibers.
The results of a series of experiments, done to determine the
relative amounts of the isozymes by their ATPase activity,
under basal conditions, are shown in Table 2. From the ouabain
inhibition data (Figs. 1 and 2), it was assumed that in the range
of 10—6 to 10 M ouabain, a2 is —90% saturated with ouabain,
whereas at has —10% bound. Then we used a concentration of
5 x 10—6 M ouabain to inhibit a2 isoform almost exclusively,
while at 10-2 M ouabain complete inhibition of both at and a2
isoforms is obtained. As shown in Table 2, the soleus of uremic
rats has a greater proportion of a2 mediated pump activity than
that of control animals, but the total Na, K-ATPase activity is
significantly reduced. On the contrary, the decrease in pump
activity in the adipose tissue is due to a parallel decrement of
the activity of both catalytic subunits.
Since Lytton, Lin and Guidotti [7] have suggested that al is
pumping at about 1/2 its maximum capacity under basal condi-
tions and a2 is pumping at only 1/20 of its capabilities, one
question of interest was to measure internal sodium dependence
on pump activity of uremic and normal adipocytes. According
to McGill and Guidotti [14], we have measured in isolated
adipocytes Ymax after cells were preincubated with 140 m Na,
in the absence of external potassium. The results of five
experiments where 86Rb uptake was measured in adipocytes
after the addition of KC1 to KC1-starved cells, were: Ymax for
al: 8.4 0.4 and 6.8 0.1 nmol 86Rb/106 cells/mm and Vmax for
a2 are: 24 1 and 14 0.5 nmol 86Rb/106 cells/mm for control
and uremic rats, respectively (P < 0.05).
Na, K-ATPase hydrolytic activity and ouabain sensitive 86Rb
influx
Both parameters were measured in kidney tissue isolated
from both groups of rats and results are mean values SE from
five to seven different animals each. In the kidney slices of
chronic renal failure rats, there was a 30% increase in ouabain-
sensitive 86Rb uptake (uremic vs. control rats 409.2 29.9 vs.
315.8 23.9 nmollg/min; P < 0.05, N =5). In these transversal
kidney slices there was no inhibition in 86Rb uptake with 5 x
10—6 M ouabain in either group of rats. The hydrolytic activity
was measured in kidney homogenates of control and uremic
rats; in uremic rats there was a 27.7% increment of the Na,
K-ATPase activity (uremic vs. control rats 26.9 1.1 vs. 21.0
1.4 mol P1/mg protein/hr; P < 0.01, N = 7).
We also measured Na, K-ATPase specific activity in muscle
homogenates. In soleus homogenates of chronic renal failure
rats, there was a 45% decrement of the Na, K-ATPase specific
activity (uremic vs. control rats 1.47 0.08 vs. 2.70 0.15
pmol P1/mg proteinlhr; P < 0.01, N = 6).
It is of interest that the yield of inhibition of muscular pump
of uremic animals measured in whole homogenate was similar
to that observed in the 86Rb uptake of muscular fibers. It is
known that in isolated muscle, measurements of the Na,
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Fig. 1. Ouabain inhibition of RB/K uptake in skeletal muscle of
control (A) and uremic (B) rats. Soleus muscle were incubated at 37°C
for 30 minutes in KRBG buffer containing various concentrations of
ouabain, as described in the Methods. The curves represent the best fit
of the data to a two-component model, as determined by nonlinear least
square analysis of 5 experiments done in triplicates. Control: low
affinity component Ki = 1.1 5.7 X i0 M ouabain; high affinity
component, Ki 9.3 0.7 x l0 M ouabain (regression coefficient, r2
= 0.999). Uremic: low affinity component, Ki = 4.3 0.4 X 10-6 M
ouabain; high affinity component Ki = 3.6 0.4 x i0 M ouabain (r2
= 0.999).
K-ATPase activity by adding 86Rb and ouabain will only give an
approximation of the total activity, since isolated skeletal
muscles use only 3 to 25% of total capacity for active K
transport [9].
Ouabain inhibition of 86RbIK uptake
For comparison, Na, K-ATPase activity of control and
uremic rats was measured in adipocytes and skeletal muscle
fibers by 86Rb/K uptake using various concentrations of
ouabain. The sensitivity of Na, K-ATPase inhibition by ouabain
in normal and chronic renal failure rats was analyzed by curve
fitting to a two-site inhibition model, as previously described
[7]. The derived numerical values of the Na,K-pump activities
associated with each site and their respective Ki's from control
and uremic tissues are summarized in Figures 1 and 2. The two
component inhibition model gave the best fit of the data
Fig. 2. Ouabain inhibition of Rb/K uptake in adipocytes of control (A)
and uremic (B) rats. Suspensions of adipocytes (30% in KRPA) were
preincubated for 15 minutes at 37°C with the indicated concentration of
ouabain. The incubation was then continued by the addition of isotope
and quenched 5 minutes later by spinning aliquots through oil, as
indicated in the Methods. The average SE of triplicate determinations
in different experiments are shown (control N = 8; uremic N = 5). The
curves represent the best fit of the data to a two-component inhibition
model, determined by nonlinear least squares analysis. Control: low
affinity component, Ki = 5.6 0.5 x l0 s ouabain; high affinity
component, Ki = 4.7 3.1 x i0 Mouabain (regression coefficient, r2
= 0.997). Uremic: low affinity component, Ki = 3.0 2.10 x iO M
ouabain; high affinity component 1.2 7.7 x lO M ouabain (r2 =
0.998).
(regression coefficient, r2 = 0.999 for each curve). As shown in
the graph, the high affinity component represented 61.1 13%
of the total enzyme activity in the uremic muscular tissue,
whereas 46.6 0.6% was detected in control muscle. Also a
significant increment in ouabain sensitivity was observed in
uremic skeletal tissue with changes in the K05 of the high and
the low affinity components, as compared to control soleus
(Fig. 1; P < 0,05). Values in control animals are in agreement
with previous data [7].
In adipose tissue (Fig. 2) no significant changes in the
percentage of the high affinity component were observed during
chronic renal failure: values for control and uremic adipocytes
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were 66.0 3.8% and 59.1 3.0%, respectively. Nevertheless,
in uremia there was a minor but significant shift in the ouabain
binding of the high-sensitivity component from 4.7 X 10—8 M to
1.2 x 10 M, control versus uremic, P <0.05 Again the results
in normal adipocytes are in agreement with those of Lytton et a!
[7].
Northern analysis of the a mRNAs
The quantification of a isoforms by ATPase activity clearly
shows that the amount of a! and a2 isoforms is decreased in
adipose tissue during chronic renal failure, while there is only a
decrement of the a! isoform in skeletal muscle of the same rats.
On the other hand, it is well known that renal tissue is adapted
to renal insufficiency by increasing the number of Na,
K-pumps, as confirmed above by us.
We decided, therefore, to investigate whether or not these
changes in the enzyme are due to a parallel changes in the
amount of the transcripts encoding the al and a2-subunits. Two
mRNAs encoding the a2 subunit have been identified [20]. In a
previous work [15], we only detected one form because we did
Fig. 5. Na, K-ATPase al isoforms mRNA levels in response to chronic
renal failure. Northern blot analysis of adipose, kidney and muscle
tissue from control (1, 3 and 5, respectively) and uremic (2, 4 and 6,
respectively) rats, was performed as indicated under experimental
procedures. These blots are representative of 3 separate experiments.
not wash with 50 mrvi NaOH before RNA transference. When
total RNA isolated from the skeletal muscle, adipocytes and
renal tissue of uremic rats were probed with the a2-specific
cDNA probe, a divergent pattern was observed. Whereas in
uremic muscle the amounts of the a2 transcripts were found to
be increased over those present in the normal soleus, the
opposite was observed in adipose tissue. Figure 3 shows a
representative Northern blot of skeletal muscle, adipose tissue
and kidney mRNA that had been hybridized to the a2-isoform
specific probe. The two a2-mRNA species (3.4 and 5.3 kb) were
detected in all samples, except kidney. Changes in abundance
(sum of the 2 bands) are included in Figure 4. On the other
hand, the amounts of the al transcripts in adipocytes and
skeletal muscle fibers were decreased during chronic renal
failure, while a notorious increment in the amount of the a! was
found in kidney tissue (Fig. 5). These results are not surprising
because it shows correlation between the al isoform activity of
the Na, K-ATPase and the amounts of the transcripts for this
isoform in the three tissues studied. Abundance of the alpha 1
isoform mRNAs in adipose cells, muscle fibers and renal tissue
is included in Figure 6.
Therefore, Northern analysis shown here indicates that the
regulation of the Na, K-ATPase in response to chronic renal
failure is quite different from one tissue to another.
Discussion
The present study demonstrates that there is a differential
regulation of the in vivo expression of the Na, K-ATPase
isoforms in chronic renal failure, namely a large and specific
decrease in the expression of the a! isoform of the extrarenal
tissue (skeletal muscle and adipose), whereas an increment in
the al expression in the kidney was observed. The differential
expression of the distinct a isoforms mRNAs in different tissues
most likely fulfills specialized requirements for cation ho-
meostasis during chronic renal failure. An increase in renal
tubular and colonic potassium secretion has been demonstrated
in several chronic conditions, that is, during periods of heavy
potassium intake, hyperaldosteronism and renal insufficiency.
Although patients or experimental animals with chronic renal
failure generally maintain a fairly satisfactory water and elec-
trolyte status due to the compensatory action of surviving
Fig. 3. Na, K-A TPase a2 isoform mRNA levels and GAPDH mRNA in
response to chronic renal failure. Northern blot analysis of adipocytes,
kidney and soleus muscle from control (1, 3 and 5, respectively) and
uremic rats (2, 4 and 6, respectively). These blots are representative of
4 separate experiments.
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nephrons, there is an impaired extrarenal disposal of an acute
oral potassium load [12, 21]. We have recently demonstrated a
reduction in the Na, K-ATPase activity in the skeletal muscle of
uremic rats due to a diminished al isoform catalytic activity and
mRNA expression [15]. These results were extended in the
present conditions where we have compared skeletal muscle
with adipose and renal tissues. It is known that skeletal muscle
is the major storage of body potassium and is actively involved
in extrarenal potassium handling; meanwhile, a single fat drop-
let accounts for most of the intracellular volume of adipocytes.
Nevertheless, both tissues have hormone-dependent Na,K-
pump activity [7]. On the other hand, the kidney is the main
organ involved in body potassium homeostasis.
In fact, after reduction in the population of functioning
nephrons, in chronic renal failure, potassium balance is main-
tained despite of a constant intake of potassium because of a
proportional increase in the rate of potassium secretion by
surviving nephrons [22]. The increased capacity for potassium
excretion per nephron correlates with a rise in Na, K-ATPase
activity in renal tissue [10]. Using Northern RNA analysis, we
have demonstrated that the amount of a! isoform mRNA in the
kidney is significantly higher in uremic rats compared to con-
trols. This increase in the Na, K-ATPase catalytic al isoform
described in the present work correlates well with the increased
enzyme activity which has been shown by several authors [10,
22, 23].
The increment in the abundance of al isoform mRNA mea-
sured in the remnant renal tissue contrasted with the diminished
a! mRNA of soleus and adipose tissue from chronic renal
failure rats. The changes in the abundance of al subunit
mRNAs in uremic tissues correlate well with the a! catalytic
activity of the pump in the three tissues studied. Although
modifications in pump activity could be brought about by
changes in the half-life of the pump protein or by a change in the
synthesis rate of the protein associated with increments or
decrements in the abundance of al catalytic isoform mRNA. In
fact, others have not found a relationship between protein
abundance and the respective mRNA in the thyroid induction of
rat myocardial Na-pump [24].
When we have compared the expression of a2 subunit mRNA
in skeletal muscle and adipose tissue, a different pattern of
expression for the a2 isoform mRNAs was observed. Whereas
the abundance of a2 mRNA decreased by 50% in adipose
tissue, an increment was observed in the soleus muscle fibers.
The decrement in the abundance of adipocyte a2 mRNA
correlates with the diminished pump activity of this isoform
under basal and "max conditions. However, no such relation-
ship was observed in soleus muscle. In this tissue, there is an
increase in the abundance of a2 mRNA without significant
changes in the pump activity of this isoform. We have not
measured Vmax in soleus fibers, but since there is an increment
in intracellular Na in uremia, this will favor the a2 pump
activity. Possibilities for the lack of correlation between the
amounts of mRNAs and the active protein are that the tran-
scripts are not translated or there are changes in the turnover of
the protein. Hsu and Guidotti [25] have shown in muscles of
hypokalemic rats, in which the a2 isoform of the Na, K-ATPase
is substantially reduced, an increment in the amount of the
transcripts for this polypeptide. On the other hand, it is inter-
esting that the there is an enhanced insulin sensitivity in the Na,
K-pump activity of uremic soleus muscle [12] since it is known
that a2 isoform is hormone sensitive.
Our studies have compared Northern blots of the catalytic
isoforms of the Na pump with GAPDH mRNA. We do not have
further evidence that GAPDH is transcribed at a constant rate
in uremia. Yet, GAPDH Northern blot has similar values in
control and experimental animals. It is known that GAPDH
promoter is sensitive to insulin [26] and these results would
suggest that, even though uremia is characterized by insulin
resistance, this is not a general phenomenon, as indicated above
[12].
Our data are in agreement with previous observations in
several control rat tissues, since in adipocytes and skeletal
muscle [20] the a2 and a! subunits have been identified, and
their respective sensitivities to ouabain are very close to the
present results [7]. The presence in the kidney of isoform other
than al remains controversial [27—29], The fact that the ouabain
sensitivity of the two populations of Na, K-ATPase was en-
hanced in the uremic soleus muscle suggests that the affinity for
ouabain may not depend solely on the structure of the isoform,
but also on other cell-specific factors: for example, the al
isoform, which is classically the most ouabain resistant isoform,
exhibits quite different affinities for ouabain from one species to
another, or even with one species [30, 31].
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Our studies altogether these results indicate contrasting ef-
fects of uremia on the expression of the catalytic isoforms of
Na, K-ATPase. In each tissue examined, the abundance of
mRNA transcripts encoding the a isoforms were tissue-specif-
ically regulated. These results are particularly interesting be-
cause it is known that the expression of the Na, K-ATPase can
be regulated in cells and in whole animals by hormones and
growth conditions. The expression of the genes for the at and
a2 has been ascribed to change during myocyte differentiation
[32, 33], hypokalemia [25, 34], in hypertension [16], and after
exposure to thyroid hormones [5, 19, 35], among others [36].
Although hormonal levels are altered in chronic renal failure [9,
10], there is not a clear explanation for the divergence in the
expression of the different a isoforms in the three uremic tissues
studied. The "switch" in the expression of the Na, K-ATPase
a subunit isoforms remains unknown.
The demonstration that during chronic renal failure the
amount of the catalytic isoforms of the Na, K-ATPase is tissue
variable in their activity and expression is unexpected. This
may apply equally as well to other tissues or physiological
conditions.
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